4//SEC Filing
Claypoole Robert E 4
Accession 0002005474-26-000002
CIK 0001665988other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:30 PM ET
Size
8.3 KB
Accession
0002005474-26-000002
Insider Transaction Report
Form 4
Claypoole Robert E
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Class A Common Stock
2026-01-09+93,750→ 158,714 total - Tax Payment
Class A Common Stock
2026-01-09$8.03/sh−41,717$334,988→ 116,997 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-01-09−93,750→ 187,500 total→ Class A Common Stock (93,750 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- [F2]The RSUs shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact|2026-01-13
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0002005474
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:30 PM ET
- Size
- 8.3 KB